(NOLA-B) Nolato (publ) - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015962477

NOLA-B EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of NOLA-B over the last 5 years for every Quarter.

NOLA-B Revenue

This chart shows the Revenue of NOLA-B over the last 5 years for every Quarter.

NOLA-B: Medical Devices, Laboratory Products, Packaging Solutions, Industrial Components

Nolato AB (publ) is a global manufacturing company specializing in precision polymers, serving various high-tech industries, including medical technology, pharmaceuticals, consumer electronics, telecom, automotive, and hygiene. With a presence in Sweden, Hungary, Asia, Europe, and North America, the company leverages its expertise in plastic, silicone, and thermoplastic elastomer products to deliver customized solutions.

The companys product portfolio is diverse, encompassing catheter balloons, breathing bags, non-conductive sealing and damping silicone products, primary plastic packaging for medicines, and various laboratory products. Nolato also offers advanced manufacturing technologies, including injection molding, extrusion, and cleanroom production, as well as design and virtual prototyping solutions. Its products are designed to meet the stringent requirements of its clients, often serving as critical components in medical devices, pharmaceutical packaging, and electronic applications.

Given its strong market position and diversified product offerings, Nolato is well-positioned to capitalize on growth trends in its target markets. The medical technology and pharmaceutical sectors, in particular, are expected to drive demand for the companys high-precision products. With a proven track record of innovation and a commitment to quality, Nolato is poised for continued success.

Analyzing the , we observe that Nolatos stock price has been trending upward, with the short-term moving averages (SMA20 and SMA50) indicating a positive momentum. The stock is currently trading above its 50-day and 200-day moving averages, suggesting a strong uptrend. The Average True Range (ATR) of 1.94, equivalent to 3.28%, indicates moderate volatility. Using this data, we can forecast that Nolatos stock price may continue to rise, potentially reaching 62.50 SEK in the near term, driven by the companys strong fundamentals and favorable market trends.

Examining the , we note that Nolatos market capitalization stands at 15,947.11M SEK, with a Price-to-Earnings (P/E) ratio of 22.90. The Return on Equity (RoE) of 12.70% indicates that the company is generating strong returns for its shareholders. By combining these fundamental metrics with the technical analysis, we can predict that Nolatos stock price will continue to appreciate, driven by the companys solid financial performance and growth prospects. Our forecast suggests a potential price target of 65.00 SEK within the next 6-12 months, representing a 9.6% upside from current levels.

Additional Sources for NOLA-B Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

NOLA-B Stock Overview

Market Cap in USD 1,601m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Commodity Chemicals
IPO / Inception

NOLA-B Stock Ratings

Growth Rating -11.4
Fundamental 40.7
Dividend Rating 9.10
Rel. Strength 9.36
Analysts -
Fair Price Momentum 51.75 SEK
Fair Price DCF 114.94 SEK

NOLA-B Dividends

Dividend Yield 12m 2.71%
Yield on Cost 5y 2.74%
Annual Growth 5y -36.03%
Payout Consistency 81.7%
Payout Ratio 57.9%

NOLA-B Growth Ratios

Growth Correlation 3m 38.5%
Growth Correlation 12m 25.3%
Growth Correlation 5y -57.1%
CAGR 5y 0.52%
CAGR/Max DD 5y 0.01
Sharpe Ratio 12m -1.59
Alpha -10.87
Beta 0.645
Volatility 34.72%
Current Volume 528.6k
Average Volume 20d 120.5k
What is the price of NOLA-B shares?
As of June 24, 2025, the stock is trading at SEK 56.25 with a total of 528,646 shares traded.
Over the past week, the price has changed by -2.60%, over one month by +0.45%, over three months by -3.13% and over the past year by -0.55%.
Is Nolato (publ) a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, Nolato (publ) (ST:NOLA-B) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.67 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NOLA-B is around 51.75 SEK . This means that NOLA-B is currently overvalued and has a potential downside of -8%.
Is NOLA-B a buy, sell or hold?
Nolato (publ) has no consensus analysts rating.
What are the forecasts for NOLA-B share price target?
According to our own proprietary Forecast Model, NOLA-B Nolato (publ) will be worth about 57.1 in June 2026. The stock is currently trading at 56.25. This means that the stock has a potential upside of +1.44%.
Issuer Target Up/Down from current
Wallstreet Target Price 64.3 14.2%
Analysts Target Price - -
ValueRay Target Price 57.1 1.4%